Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Mar;23(3):163-7.
doi: 10.1007/s10096-003-1084-2. Epub 2004 Feb 19.

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

Affiliations
Comparative Study

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

R Colodner et al. Eur J Clin Microbiol Infect Dis. 2004 Mar.

Abstract

Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77-21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76-5.91), age over 60 years (OR=2.65, 95%CI, 1.45-4.83), diabetes (OR=2.57, 95%CI, 1.20-5.51), male gender (OR=2.47, 95%CI, 1.22-5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17-4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7-143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2-24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8-9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6-9.0).

PubMed Disclaimer

References

    1. JAMA. 1999 Feb 10;281(6):517-23 - PubMed
    1. Rev Infect Dis. 1988 Jul-Aug;10(4):867-78 - PubMed
    1. Clin Infect Dis. 2000 Mar;30(3):473-8 - PubMed
    1. Pharmacotherapy. 1999 Aug;19(8 Pt 2):120S-128S; discussion 133S-137S - PubMed
    1. Med Sci Monit. 2002 Jan;8(1):CR44-7 - PubMed

Publication types

MeSH terms